Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
160.8 USD | -0.56% | -3.87% | +3.77% |
04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
04-29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.77% | 286B | |
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+17.65% | 326B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.79% | 154B | |
-3.34% | 149B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Says CMHP Recommends European Approval of Risankizumab for Treatment of Crohn's Disease